Revision Year: 2007
Atenativ 50 IU/mL, powder and solvent for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder and solvent for solution for infusion. Atenativ is supplied in freeze-dried form. The concentrate is administered intravenously after reconstitution in the accompanying solution. |
Atenativ is presented as a powder and solvent for solution for infusion containing 500 IU, 1000 IU or 1500 IU lyophilised human plasma-derived antithrombin per vial.
The product contains 50 IU/mL human plasma-derived antithrombin when reconstituted with the accompanying solution (water for injections), i.e. 10 mL (500 IU), 20 mL (1000 IU), 30 mL (1500 IU).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Antithrombin III |
Antithrombin III is a small glycoprotein anticoagulant that inactivates several enzymes of the coagulation system and accounts for most of the antithrombin activity in plasma. It is a member of the serpin superfamily. |
| List of Excipients |
|---|
|
Sodium chloride Solvent/Diluent: water for injection. |
Injection vial of type II glass (Ph.Eur.), 50 or 100 mL with a bromobutyl rubber stopper sealed with an aluminium pull-off cap.
| Drug | Countries | |
|---|---|---|
| ATENATIV | Austria, Estonia, Spain, Finland, France, Croatia, Lithuania, Netherlands, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
